Spinal Cord injury: Regeneration

This feed describes the advancement in spinal cord regeneration research and potential nerve regeneration treatments after spinal cord injuries.

September 29, 2020
Review
Open Access

Role of vitamin B12 deficiency in ischemic stroke risk and outcome

Neural Regeneration Research
Gyllian B YahnNafisa M Jadavji
October 9, 2020

Recent progress in therapeutic drug delivery systems for treatment of traumatic CNS injuries

Future Medicinal Chemistry
Bikram KhadkaJong-Sup Bae
September 29, 2020
Review
Open Access

Physiopathology of ischemic stroke and its modulation using memantine: evidence from preclinical stroke

Neural Regeneration Research
Hilda MartInez-CoriaHéctor E López-Valdés
October 13, 2020

Neuroactive Peptide Nanofibers for Regeneration of Spinal Cord after Injury

Macromolecular Bioscience
Melike Sever-BahcekapiliAyse B Tekinay
September 29, 2020
Review
Open Access

Saccharomyces cerevisiae in neuroscience: how unicellular organism helps to better understand prion protein?

Neural Regeneration Research
Takao Ishikawa
October 2, 2020

Self-assembling multidomain peptide hydrogels accelerate peripheral nerve regeneration after crush injury

Biomaterials
Tania L Lopez-SilvaJeffrey D Hartgerink
September 29, 2020
Review
Open Access

Postnatal therapeutic approaches in genetic neurodevelopmental disorders

Neural Regeneration Research
Gilad Levy, Boaz Barak
October 11, 2020

Combined use of platelet-rich plasma and adipose tissue-derived mesenchymal stem cells shows a synergistic effect in experimental spinal cord injury

Journal of Chemical Neuroanatomy
Reza SalariniaHamidreza Sadeghnia
October 2, 2020
Open Access

Functional rewiring across spinal injuries via biomimetic nanofiber scaffolds

Proceedings of the National Academy of Sciences of the United States of America
Sadaf UsmaniLaura Ballerini
September 29, 2020
Review
Open Access

MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration: advances and limitations

Neural Regeneration Research
Bridget Martinez, Philip V Peplow
October 14, 2020

Click chemistry based biopolymeric hydrogels for regenerative medicine

Biomedical Materials
Ya LiLiyang Shi
October 1, 2020
Open Access

Satellite glial cells promote regenerative growth in sensory neurons

Nature Communications
Oshri AvrahamValeria Cavalli
October 25, 2020

CCR2 downregulation attenuates spinal cord injury by suppressing inflammatory monocytes

Synapse
Qingpu ZhangZhongli Zhang

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS - Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementias present as cognitive decline that is not a part of normal aging. Age-related dementias include Alzheimer's disease, vascular dementia, and Lewy body dementia. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/spinal-cord-injury-regeneration/78767165-2007-4502-9441-8a412f74293e